Pipeline

AZAD continually invests into further development and expansion of its FP portfolios. Development and validation of FPs  is undertaken at EU-based contract manufacturers facilities under the direction of Azad`s pharmaceutical and regulatory specialists to produce CTD-format Dossiers, which are then out-licensed for customers to submit marketing authorization applications worldwide (ex-USA).

Finished Products

Product Therapeutic Indication Status
Brinzolamide + Brimonidine, 10 mg/mL + 2 mg/mL, eye drops suspension, preservative-free Treatment of Glaucoma Under development
Brinzolamide, 10 mg/ml, eye drops suspension, preservative-free Treatment of Glaucoma Under development
Ferric Carboxymaltose, 50 mg/ml, concentrate for solution for infusion Treatment of Iron Deficiency Under development